Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromesSheila Weiss Smith, Amy J. Davidoff, Ke Xu et al.|Haematologica|2011Cited by 40
Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort studyTetsuya Ogawa, Kosaku Nitta, Tetsuri Yamashita et al.|International Urology and Nephrology|2013Cited by 25
Relation of Carotid Intima-Media Thickness and Silent Cerebral Infarction to Cardiovascular Events and All-Cause Mortality in Chronic Hemodialysis PatientsMasayo Sato, Kosaku Nitta, Kuniaki Otsuka et al.|Internal Medicine|2012Cited by 15
Stiffness parameter β as a predictor of the 4-year all-cause mortality of chronic hemodialysis patientsMasayo Sato, Kosaku Nitta, Tetsuya Ogawa et al.|Clinical and Experimental Nephrology|2012Cited by 13
Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patientsTetsuya Ogawa, Kosaku Nitta, Ai Kyono et al.|Clinical and Experimental Nephrology|2012Cited by 10